
Organometallics p. 1174 - 1177 (1985)
Update date:2022-09-26
Topics:
Cotton, F. Albert
Duraj, Stan A.
Roth, Wieslaw J.
Two compounds (η5-C5H5)2V2(C 6H5CO2)4, 1, and (η5-C5Me5)2V2(C 6H5CO2)4, 2, have been prepared from vanadocene and decamethylvanadocene, respectively, and characterized by single-crystal X-ray crystallography. The data are as follows. For 1: P1; a = 10.640 (2) A?, b = 10.774 (3) A?, c = 8.510 (2) A?, α = 112.83 (2)°, β = 101.41 (2)°, γ = 69.43 (2)°, V = 839.6 (6) A?3, Z = 1, R1 = 0.0477, R2 = 0.0547. For 2: C2/c; a = 11.576 (3) A?, b = 16.721 (2) A?, c = 21.452 (2) A?, β = 90.45 (3)°, V = 4152 (3) A?3, Z = 4, R1 = 0.0733, R2 = 0.0885. The V-V′ distances of 3.636 (1) A? for 1 and 3.652 (2) A? for 2 suggest that little if any direct bonding occurs between two vanadium atoms. The presence of pentamethylcyclopentadienyl ligands in the axial positions in 2 causes a twist of the four carboxylate bridges with torsional angles for the two independent O-V-V′-O′ units equal to 5.9° and 10.9°. In the cyclopentadienyl derivative 1 the corresponding torsional angles are each 2.6°.
Shanghai Haoyuan Chemexpress Co., Ltd.
website:https://www.chemexpress.com/
Contact:86-21-58950125
Address:No.3 Building, No.1999, Zhangheng Road, ZhangjiangHighTech Park, Shanghai, P.R.China,201203
Nanjing Raise Pharmatech Co., Ltd
website:http://www.raisechem.com
Contact:+86-25-58649566
Address:B381,No.606,Ningliu Road,Jiangbei New Area,Nanjing,Jiangsu Province,China
QINGDAO ON-BILLION INDUSTRAIL CO.,LTD
website:http://www.obn.com.cn
Contact:+86-15005320811 +86-532-80681989
Address:F35 Parkson Mansion No.44-60 Zhongshan Rd.
Angelisun(Chongqing) Pharmaceutical Co., LTD.
Contact:+86-23-68030926-816
Address:D1-7 Tech & Entrepreneurs Park, Kecheng Road, Erlang Hi-Tech Areas, Chongqing, China
taizhou creating bio-pharm co.,ltd.
Contact:+86- 576- 88827176
Address:715 room ,unit A.junyue Building,Jiaojiang,Taizhou,Zhejiang,China
Doi:10.1007/BF00773527
()Doi:10.1021/ja01364a041
(1930)Doi:10.1039/c3ob27504c
(2013)Doi:10.1016/S0040-4039(98)00344-X
(1998)Doi:10.1039/b710640h
(2008)Doi:10.3390/pharmaceutics10030154
(2018)